NCT00814021 2026-04-15
Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain
Institut Claudius Regaud
Phase 2 Completed
Clinical Trials
561 trialsNCT03846128 2026-04-14
BIOSUNTOX
University Hospital, Rouen
Terminated
NCT06525831 2026-04-14
Rein3DP-M
University Hospital, Bordeaux
Phase NA Recruiting
NCT07117227 2026-04-14
RCCETT
Peking University Third Hospital
Recruiting
NCT07527637 2026-04-14
Risk of Scrotal Hydroceles After Nephrectomy For Kidney Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Completed
NCT05210933 2026-04-13
SMART
University of Alberta
Suspended
NCT05969496 2026-04-13
NEOPAX
University of Colorado, Denver
Phase 2 Recruiting
NCT02087852 2026-04-09
Kidney Cancer DNA Registry
Memorial Sloan Kettering Cancer Center
Recruiting
NCT00579514 2026-04-07
Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients
Memorial Sloan Kettering Cancer Center
Phase NA Active not recruiting
NCT02964078 2026-04-02
Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT07401875 2026-04-02
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT06532422 2026-04-01
NEPHRAMBU
GCS Ramsay Santé pour l'Enseignement et la Recherche
Recruiting
NCT06948552 2026-04-01
Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA
Henry Ford Health System
Phase 2 Recruiting
NCT07234656 2026-04-01
PP-RECURK
Gødstrup Hospital
Recruiting
NCT03786796 2026-03-30
ORCHID
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Recruiting
NCT07123090 2026-03-25
SPARCC
Dana-Farber Cancer Institute
Phase 2 Recruiting
NCT05700461 2026-03-20
Drug Screening Using Novel IMD in Renal Cell Carcinoma
Brigham and Women's Hospital
Phase 1 Enrolling by invitation
NCT06126159 2026-03-20
MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular Markers
Chang Gung Memorial Hospital
Phase NA Active not recruiting
NCT06882486 2026-03-20
NAMECAR
Institut Paoli-Calmettes
Phase NA Recruiting
NCT07397611 2026-03-20
Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC
Dana-Farber Cancer Institute
Phase 2 Recruiting
NCT03185039 2026-03-19
Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents
Institut Paoli-Calmettes
Phase NA Active not recruiting
NCT07004426 2026-03-19
KIDCaD
Charles University, Czech Republic
Completed
NCT05384821 2026-03-18
MetroWilms
Centre Oscar Lambret
Phase 1/2 Recruiting
NCT05888532 2026-03-17
64Cu-GRIP B in Patients With Advanced Malignancies
University of California, San Francisco
Phase 1/2 Recruiting
NCT02121730 2026-03-16
FRISC
Centre Hospitalier Universitaire, Amiens
Completed
NCT02439008 2026-03-13
Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response
Centre Oscar Lambret
Phase NA Terminated
NCT03652298 2026-03-13
NeuroPrevPTSD
Centre Oscar Lambret
Phase 2 Terminated
NCT03996850 2026-03-13
SPECT/CT for the Characterization of Renal Masses
Jonsson Comprehensive Cancer Center
Active not recruiting
NCT03239145 2026-03-12
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
Phase 1 Completed
NCT07050771 2026-03-12
Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
The Methodist Hospital Research Institute
Phase 2 Recruiting
NCT04987086 2026-03-11
68Ga-PSMA PET in the Renal Cell Carcinoma
Xijing Hospital
Phase NA Recruiting
NCT07077083 2026-03-11
CAIX PET/CT
Massachusetts General Hospital
Phase 2 Not yet recruiting
NCT02346435 2026-03-05
DISSRM
Abramson Cancer Center at Penn Medicine
Recruiting
NCT05946993 2026-03-04
LIAM Mc
University College Cork
Phase NA Active not recruiting
NCT07297160 2026-03-04
CALySSEY
Baylor College of Medicine
Phase 1 Not yet recruiting
NCT07088536 2026-03-03
OCCURORTW
Jagiellonian University
Recruiting
NCT06959433 2026-02-27
Lu-177 PSMA Treatment in Cell Renal Carcinoma
Ankara University
Phase 3 Not yet recruiting
NCT07243067 2026-02-27
Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
Mayo Clinic
Not yet recruiting
NCT05225428 2026-02-25
VERDI
Dana-Farber Cancer Institute
Phase NA Recruiting
NCT05672459 2026-02-25
A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors
M.D. Anderson Cancer Center
Phase 1/2 Active not recruiting
NCT06964958 2026-02-24
LASER
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
NCT04258462 2026-02-23
Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors
University of California, San Francisco
Phase 2 Active not recruiting
NCT07410676 2026-02-18
EBNK-ST-001
Essen Biotech
Phase 1/2 Recruiting
NCT05487859 2026-02-17
Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)
University of Alabama at Birmingham
Phase 2 Withdrawn
NCT07413120 2026-02-17
Efficacy and Safety of VasoClip® vs. WeckClip® for Robotic Urologic Surgery
Incheon St.Mary's Hospital
Phase 3 Completed
NCT00458536 2026-02-09
Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF
Beth Israel Deaconess Medical Center
Phase 1/2 Completed
NCT07395037 2026-02-09
WASHOUT
British Urology Researchers in Surgical Training
Recruiting
NCT03203473 2026-02-06
Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study)
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
NCT06349668 2026-02-05
SMILe
University Hospital, Linkoeping
Phase 3 Recruiting
NCT02950766 2026-02-03
NeoVax Plus Ipilimumab in Renal Cell Carcinoma
Dana-Farber Cancer Institute
Phase 1 Active not recruiting